Bivona, Trever G
- University of California, San Francisco · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,810
- Sustained Excellence
- Program Leader
- R01 Holder
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2011 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$3M
Full award amounts, FY2023
Award Records
6
Records listing this PI
Award-Linked Rank
#1,810
By linked amount among FY2023 PIs
Earliest Year Loaded
2011
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Bivona, Trever G as a PI. Multi-PI records show the full award amount for context.
- 5U54CA224081-06U54Contact PIBAY AREA & ANDERSON TEAM AGAINST ACQUIRED RESISTANCE - U54 PROGRAM (BAATAAR-UP)University of California, San Francisco · Internal Medicine (NIH department code)$1.1Maward amount
- 1R01CA279180-01R01Contact PIDissecting the role and mechanism of EML4-ALK condensates in oncogenic signaling and tumor growthUniversity of California, San Francisco · Internal Medicine (NIH department code)$670.2Kaward amount
- 5R01CA231300-05R01Contact PI(PQ7) Defining a new mode of RAS signaling in cancer from cytoplasmic protein granulesUniversity of California, San Francisco · Internal Medicine (NIH department code)$448.6Kaward amount
- 5R01CA204302-07R01Contact PICharacterization of YAP as a rational companion target in lung cancerUniversity of California, San Francisco · Internal Medicine (NIH department code)$375.9Kaward amount
- 5R01CA169338-10R01Contact PIRational Combined Inhibition of NF-kB and EGFR to Optimize Lung Cancer TreatmentUniversity of California, San Francisco · Internal Medicine (NIH department code)$375.9Kaward amount
- 3U54CA224081-06S1U54Contact PIARTNet NOSI SupplementUniversity of California, San Francisco · Internal Medicine (NIH department code)$80.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Bivona, Trever G as a PI.
FY2023 award administered by University of California, San Francisco (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2011First NIH AwardUniversity of California, San Francisco
- 2012$500K Cumulative Funding
- 2012$1M Cumulative Funding
- 2012$2M Cumulative Funding
- 2012Entered Top 50% NationallyRanked #1944
- 2012Entered Top 25% NationallyRanked #1944
- 2012Entered Top 10% NationallyRanked #1944
- 2015R01 Grant Holder
- 2017$5M Cumulative Funding
- 2017Program/Center Grant Leader
- 2019$10M Cumulative Funding